Journals / Damar Cerrahi Dergisi / 2006 / Cilt: 15 - Sayı: 1

Clinical healing after iloprost in poor distal arterial bed

Distal yatak yokluğunda uygulanan iloprost sonrası klinik iyileşme

Pages
21–24
Publication Date
2022-10-10
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

We think that by determination of iloprost effectivity with prospective randomized studies with more cases, it can be a.valuable alternative for routine therapy.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Purpose: In this study, we evaluated to effectiveness and clinical benefit of iloprost that alternative therapy in patients with chronic and critical lower limb ischemia who were not candidate for surgery because of poor distal arterial bed.
📊
Key Findings & Data:Surgery was performed to bypass stenoses located proximal to crural arteries in 8 patients.
💡
Conclusion & Impact:We think that by determination of iloprost effectivity with prospective randomized studies with more cases, it can be a.valuable alternative for routine therapy.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Purpose: In this study, we evaluated to effectiveness and clinical benefit of iloprost that alternative therapy in patients with chronic and critical lower limb ischemia who were not candidate for surgery because of poor distal arterial bed. Methods: Clinical response for iloprost administration evaluated in sixteen patients. Surgery was performed to bypass stenoses located proximal to crural arteries in 8 patients. Patients were grouped into combined treatment group in which patients who had a bypass procedure were included, and medical treatment group in which patients who had only iloprost administration were included.A comparative analysis of improvement in clinical findings was performed between two groups. Recession of rest pain, reduce of need for analgesic drug usage, healing of limb wound, ABI (ankle / brachial pressure index) and increasing of walk interval without pain evaluated in this cases. Results: After the therapy, pain severity and need for analgesic drug were reduced and walk interval increased in all patients. Patient's Fontaigne class was decreased after the therapy. Improvement in ABI of combined treatment group was better than that of medical therapy group. Conclusion: Iloprost usage may be useful in patient's with poor arterial distal bed and may also benefit in combining of the surgery in proximal arterial stenosis. We think that by determination of iloprost effectivity with prospective randomized studies with more cases, it can be a.valuable alternative for routine therapy.

Özet

Amaç: Çalışmamızda kronik ciddi alt ekstremite iskemisi olan olgular ve distal yatağı cerrahi tedaviye uygun olmayan olgularda alternatif bir tedavi iloprost uygulamasının etkinliği ve klinik faydalarının değerlendirilmesi amaçlanmıştır Yöntem: İloprost uyguladığımız 16 olgu klinik yanıtları açısından değerlendirilmiştir. Krural arterlerin proksimalindeki darlıklara yönelik olarak 8 olguda bypass operasyonları uygulanmıştır. Bypass uygulanan olgular kombine tedavi, uygulanamayanlar medikal tedavi gruplarına ayrılarak tedaviye yanıtları karşılaştırmalı olarak değerlendirilmiştir. Olgular değerlendirilirken; istirahat ağrısının gerilemesi, ağrı kesici ihtiyacının azalması, ekstremitedeki lezyonların iyileşmesi, ABI (ayak bileği / kol basınç indeksi) ve yürüme mesafesinin artması esas alınmıştır. Bulgular: Tedavi sonrasında tüm olguların ağrı şiddetinin azaldığı, ağrı kesici ihtiyacının düştüğü ve yürüme mesafelerinin arttığı gözlemlenmiştir. Tedavi sonrasında Fontaine evrelemesine göre olguların evrelerinde gerileme sağlanmıştır. Kombine tedavi grubunda ABI değerindeki iyileşme medikal tedavi grubundan anlamlı derecede üstün olmuştur. Sonuç: Olgularımızda iloprost uygulamasının distal yatağı cerrahiye uygun olmayan olguların yanında proksimal darlıklara yönelik bypass cerrahisi ile kombine kullanımının klinik faydaları gözlemlenmiştir. Daha fazla sayıda olgu içeren prospektif çalışmalar ile iloprostun etkinliğinin belirlenip, rutin tedavide faydalı bir alternatif olabileceğini düşünüyoruz.

🔖

Cite This Article

POSACIOÚLU, H., BERBER, Ö., DURMAZ, İ., İSLAMOĞLU, F., AYIK, M. F. (2022). Clinical healing after iloprost in poor distal arterial bed. Damar Cerrahi Dergisi, Cilt: 15 - Sayı: 1, 21–24. https://ajindex.com/articles/486853

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (11)

  1. Fontaine R, Kim M, Kieny R. Die chirurgische behandlung der peripheren durchblutungsstorungen. Helv Chir Acta 1954;5/6:499-533
  2. Loosemore TM, Chalmers TC, Dormandy JA. A meta,analysis of randomized placebo control trials in Fontaine stages III and IV peripheral occlusive arterial disease. Int Angiol 1994; 13:133-42
  3. Wolfe JHN. The definition of critical ischaemia-is this a conceptof value? In: Greenhalgh RM, Jamieson CW, Nicolaides AN, eds. Limb salvage and amputation for vascular disease. London: Saunders WB, 1988; 3-10 4- Sethi GK, Bridgman AH, King L, Scott SM. Intravenous infusions of PGI1 in the management of limb ishaemia. American J Surg 1986; 52:474-478
  4. Olsson AG, Nilsson E. The effect of i.v. prostacyclin on rest pain and healing of ischaemic ulcers in peripheral artery disease. Prostaglandins in Medicine 1981; 6:329-339
  5. Kuyama T, Umemura H, Sudo T, et al. Clinical studies on various therapy for the intractable trauma of toes and fingers in cases of diabetes mellitus and peripheral ischemic diseases]. Nippon Geka Gakkai Zasshi. 1988; 89:763-770
  6. Al-Khaldi A, Al-Sabti H, Galipeau J, Lachapelle K. Therapeutic angiogenesis using autologous bone marrow stromal cells: Improved blood flow in a chronic limb ischemia model. Ann Thorac Surg. 2003 Jan; 75(1):204-9
  7. Mueller B, Stuerzebecher S, Krais T. The experimental and clinical pharmacology of Iloprost. In Dormandy JA, ed. The Pathophysiology of critical limb iscaemia andpharmacological intervention with a stable prostacyclin analogue, Iloprost. London: Royal Society of Medicine Services, 1989; 33-49
  8. U.K. Severe Limb Iscaemia Study Group. Treatment of limb threatening ischaemia with intravenous Iloprost: A randomised doubleblind placebo controlled study. Eur J Vasc Surg 1991; 5:511-516
  9. Duthois S, Cailleux N, Benosman B, Lévesque H. Tolerance of iloprost and results of treatment of chronic severe lower limb ischaemia in diabetic patients. A retrospective study of 64 consecutive cases. Diabetes Metab 2003; 29:36-43
  10. Hickey NC, Shearman P, Crowson MC, Simms MH, Watson HR. Iloprost improves femoro-distal graft flow after a single bolus injection. Eur J Vasc Surg 1991;5:19-22
  11. Meini S, De Franco V, Auteri A, Setacci C, Di Renzo M, Pieragalli D. Short-term and long-term effects of one-week treatment with intravenous iloprost in criticallimb ischemia patients. Int Angiol 2005;24:64-69. 13-Castagno PL, Mosso F, Carignano G, Leotta L, Apostolou D, Buzzachino A. Trattamento